James Seyffart: Bitwise files for AI drug discovery ETF

James Seyffart: Bitwise files for AI drug discovery ETF
Bitwise files AI drug discovery ETF

Bitwise has filed for an exchange-traded fund focused on AI drug discovery. James Seyffart described the development on social media and expressed support for such investments, stating that the entire world should be cheering for these efforts to succeed.

James Seyffart has previously commented on ETF developments, including when BlackRock filed for a buffer Bitcoin ETF with downside protection under the ticker PBIT, as reported here. He has also noted that the Roundhill memory ETF DRAM traded near its late July low at about $44.5, with the price recently around $46, according to an earlier observation. These updates highlight Seyffart's continuing focus on activity in the ETF sector.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.